Active substance
Procainamide
- US FDA 79
- Health Canada 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | injectable · injection | INTL MEDICATION | Prescription | 31 Jul 1984 |
| PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | injectable · injection | HOSPIRA | Prescription | 12 Feb 1986 |
| PROCAINAMIDE HYDROCHLORIDE | 100MG/ML; 500MG/ML | injectable · injection | NEXUS | Prescription | 13 Oct 2017 |
| PROCAINAMIDE HYDROCHLORIDE | 100MG/ML; 500MG/ML | injectable · injection | GLAND | Prescription | 22 Jul 2024 |
| PROCAINAMIDE HYDROCHLORIDE | 100MG/ML; 500MG/ML | injectable · injection | CAPLIN | Prescription | 4 Feb 2025 |
| PRONESTYL | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule · oral | APOTHECON | Discontinued | 2 Jun 1950 |
| PRONESTYL | 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 500MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | APOTHECON | Discontinued | 2 Jun 1950 |
| PRONESTYL | 250MG; 375MG; 500MG | tablet · oral | APOTHECON | Discontinued | 28 Feb 1974 |
| PROCAINAMIDE HYDROCHLORIDE | 250MG | capsule · oral | IVAX SUB TEVA PHARMS | Discontinued | 2 Dec 1976 |
| PROCAINAMIDE HYDROCHLORIDE | 250MG | capsule · oral | LANNETT | Discontinued | 11 May 1977 |
| PROCAINAMIDE HYDROCHLORIDE | 500MG | capsule · oral | LANNETT | Discontinued | 11 May 1977 |
| PROCAINAMIDE HYDROCHLORIDE | 250MG | capsule · oral | WATSON LABS | Discontinued | 3 Jun 1977 |
| PROCAINAMIDE HYDROCHLORIDE | 375MG | capsule · oral | WATSON LABS | Discontinued | 3 Jun 1977 |
| PROCAINAMIDE HYDROCHLORIDE | 500MG | capsule · oral | WATSON LABS | Discontinued | 7 Jun 1977 |
| PROCAINAMIDE HYDROCHLORIDE | 375MG | capsule · oral | IVAX SUB TEVA PHARMS | Discontinued | 14 Jun 1977 |
| PROCAINAMIDE HYDROCHLORIDE | 500MG | capsule · oral | IVAX SUB TEVA PHARMS | Discontinued | 14 Jun 1977 |
| PROCAN SR | 250MG | tablet, extended release · oral | PARKE DAVIS | Discontinued | 11 Dec 1979 |
| PROCAINAMIDE HYDROCHLORIDE | 250MG | capsule · oral | WATSON LABS | Discontinued | 17 Jul 1980 |
| PROCAINAMIDE HYDROCHLORIDE | 375MG | capsule · oral | WATSON LABS | Discontinued | 17 Jul 1980 |
| PROCAINAMIDE HYDROCHLORIDE | 500MG | capsule · oral | WATSON LABS | Discontinued | 17 Jul 1980 |
| PRONESTYL-SR | 500MG | tablet, extended release · oral | APOTHECON | Discontinued | 12 Aug 1981 |
| PROCAINAMIDE HYDROCHLORIDE | 250MG | capsule · oral | VANGARD | Discontinued | 1 Jun 1982 |
| PROCAINAMIDE HYDROCHLORIDE | 500MG | capsule · oral | VANGARD | Discontinued | 1 Jun 1982 |
| PROCAINAMIDE HYDROCHLORIDE | 500MG/ML | injectable · injection | INTL MEDICATION | Discontinued | 31 Jul 1984 |
| PROCAN SR | 1GM | tablet, extended release · oral | PARKEDALE | Discontinued | 16 Jan 1985 |
54 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| PROCAINAMIDE HYDROCHLORIDE INJECTION USP | 02184486 | 100 MG / ML | SOLUTION · INTRAVENOUS; INTRAMUSCULAR | SANDOZ CANADA INCORPORATED |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.